At a board meeting, Emily Miles explained how the FSA proposes to regulate cannabidiol (CBD), with a focus on compliance and requiring CBD to undergo a safety assessment from the FSA. She stressed that the process would also include updating the CBD public list.
“My message to the CBD industry and retailers is that you need to act responsibly when marketing and selling these products. And my message to local authorities is that as products are being rejected from our market authorization process, you may need to step up enforcement efforts. The FSA will support you in this process ”,said Miles.
There are currently no CBD food products available on the market that have completed the mandatory safety assessment and received clearance for sale. However, the CBD public listIs due to be updated shortly, which will provide a public record of credible product applications that have requested the necessary clearance.
The list will allow retailers and local authorities in England and Wales to establish the status of CBD food products and decide which applications should be prioritized.
Commenting on behalf of the Board, Professor Susan Jebb, FSA President, said: “The FSA has a duty to protect consumers. I want to take this opportunity to ask people to think carefully before taking CBD and follow the FSA’s advice on CBD products. The FSA will not hesitate to take action if evidence emerges that the products are unsafe and consumers are at great risk. “
In England and Wales, companies had until March 31 to submit novel food dossiers to the FSA so their CBD food products could legally remain on the market.
Applications for authorization of these products are necessary because they are considered “novel foods” with no history of consumption before May 1997. These products include CBD oils, supplements, tablets and sprays.